「ma」の検索結果
178件：21～25件目を表示
-
アイファガン点眼液0.1％
4 観察日 （週） プラセボとPG併用群 （ｎ＝132） 本剤とPG併用群 （ｎ＝134） ♯：P＜0.05 （t 検定） 平均値±標準偏差 N H R R ─ 4 ─ C2 23. 主要文献 1） Maruyama Y, et al.：Cornea, 2017；36：1567-1569 2） Tsujinaka A, et al.：Acta Ophthalmol, 2019；97：e948- e...
https://www.senju.co.jp/sites/default/files/product_other_file/2024-06/aiphagan_202406_C2.pdf -
千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Research Laboratories Production
http://www.senju.co.jp/english/about/ -
February 27, 2023 Senju Pharmaceutical Co., Ltd. Announcement of collaboration agreement with Alchemedicine, Inc. Senju Pharmaceutical Co., Ltd. today announced that we have entered into a collaborati...
https://www.senju.co.jp/sites/default/files/content_news/2023-02/ENG_20230227_0.pdf -
ease The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju)...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322.pdf -
ease The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju)...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322_0.pdf